Citation: L. Kemeny et al., NITRIC-OXIDE IS INVOLVED IN THE ANTIMICROBIAL ACTIVITY OF KERATINOCYTES, Journal of investigative dermatology, 108(4), 1997, pp. 625-625
Citation: As. Kenderessy et al., NITRIC-OXIDE IS INVOLVED IN THE CANDIDA-ALBICANS KILLING ACTIVITY OF KERATINOCYTES, Journal of investigative dermatology, 107(3), 1996, pp. 29-29
Authors:
KEMENY L
KENDERESSY AS
OCSOVSZKY I
MICHEL G
RUZICKA T
DOBOZY A
Citation: L. Kemeny et al., INTERLEUKIN-8 INDUCES HLA-DR EXPRESSION ON CULTURED HUMAN KERATINOCYTES VIA SPECIFIC RECEPTORS, International archives of allergy and immunology, 106(4), 1995, pp. 351-356
Authors:
SZOLNOKY G
KEMENY L
KENDERESSY AS
GYULAI R
MICHEL G
RUZICKA T
MARODI L
DOBOZY A
Citation: G. Szolnoky et al., THE INVOLVEMENT OF MANNOSE RECEPTORS IN THE CANDIDA-ALBICANS KILLING ACTIVITY OF EPIDERMAL-CELLS, Journal of investigative dermatology, 105(3), 1995, pp. 489-489
Citation: As. Kenderessy et al., QUIESCENT CELL HYPERPROLIFERATION IN NON-LESIONAL PSORIATIC SKIN BY HIGH CA2+ CONCENTRATION, Journal of investigative dermatology, 103(3), 1994, pp. 415-415
Authors:
KEMENY L
KENDERESSY AS
OLASZ E
MICHEL G
RUZICKA T
FARKAS B
DOBOZY A
Citation: L. Kemeny et al., THE INTERLEUKIN-8 RECEPTOR - A POTENTIAL TARGET FOR ANTIPSORIATIC THERAPY, European journal of pharmacology, 258(3), 1994, pp. 269-272
Authors:
HUNYADI J
KENDERESSY AS
DUDA E
BRAQUET P
DOBOZY A
Citation: J. Hunyadi et al., PLATELET-ACTIVATING-FACTOR ANTAGONISTS (BN 52021 AND BN 50730) INHIBIT TUMOR NECROSIS FACTOR-ALFA-MEDIATED CYTOTOXICITY ON MURINE L929 TUMOR-CELLS, Molecular immunology, 30(6), 1993, pp. 517-519